Sofinnova Partners
Investor profile
Investment firmVenture capital
Also recorded as: SOFINNOVA PARTNERS · Sofinnova Partners.
Deals
114
distinct rounds
Companies
78
backed
Active span
2004–2026
23 yrs
Total round €
€2.9B
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Bpifrance9
- GIMV6
- Novo Holdings6
- Forbion5
- Invus5
- Roche Venture Fund4
- Seventure Partners4
- Supernova Invest4
- Andera Partners3
- Cathay Health3
- EQT Life Sciences3
- European Circular Bioeconomy Fund (ECBF)3
- Gilde Healthcare3
- Groupe Siparex3
- IDInvest Partners3
- IRDInov3
- Kurma Partners3
- Novo Seeds3
- Sacha Loiseau3
- Schroders Capital3
- XAnge3
- 5AM Ventures2
- Amadeus Capital Partners2
- Asabys Partners2
- Auriga Partners2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 2 | €229M |
| GlycoEra | Switzerland | 2 | €157M |
| Noema Pharma | Switzerland | 2 | €135M |
| Amolyt Pharma | France | 1 | €129M |
| IOmx Therapeutics | Germany | 2 | €105M |
| Tissium | France | 2 | €100M |
| SafeHeal | France | 4 | €91M |
| Inside Secure | France | 4 | €86M |
| NanoPhoria | Italy | 1 | €84M |
| Moon Surgical | France | 2 | €81M |
| ObsEva | Switzerland | 2 | €80M |
| Merus | Netherlands | 1 | €73M |
| Bioptimus | France | 2 | €72M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| F2G | UK | 1 | €69M |
| Neurent Medical | Ireland | 1 | €63M |
| Elicit Plant | France | 2 | €62M |
| haya therapeutics | Switzerland | 1 | €57M |
| Ascendis Pharma | Denmark | 1 | €55M |
| Latent Labs | UK | 1 | €48M |
| Auris Medical | Switzerland | 1 | €46M |
| Microphyt | France | 2 | €44M |
| Breath Therapeutics | Germany | 1 | €44M |
| Aledia | France | 2 | €43M |
| Micropep | France | 3 | €40M |
| Synthace | UK | 2 | €39M |
| MISSION Therapeutics | UK | 2 | €35M |
| Sphere Fluidics | UK | 1 | €34M |
| MedDay | France | 1 | €34M |
| Verley | France | 1 | €32M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series C | €129M | 2021-07 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| GlycoEra | Series B | €114M | 2025-05 |
| Noema Pharma | Series B | €106M | 2023-03 |
| Artios | Series D+ | €99M | 2025-11 |
| NanoPhoria | Series A | €84M | 2025-10 |
| Merus | Series C | €73M | 2015-07 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| F2G | Other | €69M | 2022-08 |
| IOmx Therapeutics | Series B | €65M | 2021-10 |